BioCryst Pharmaceuticals Inc
BCRX·Stocks·Biotechnology·United States·Nasdaq·USD
Price
$8.78
Today
+0.2%
YTD
+12.7%
About
Established in 2015, BioCryst is a healthcare company from Durham, North Carolina, US. The company has a global reach, trading as BBIO on the NASDAQ GS. It works to combat genetic diseases using drugs such as transthyretin and infigratinib. BBIO stock is often in demand. Add it to your portfolio watchlist now.
Price chart
Closing price history for BCRX (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-5.88
P/S (TTM)2.86
P/B (TTM)-4.79
Market cap$2.66B
Cap tierMid-cap
Industry avg P/E-6.15
Profitability
Gross margin97.52%
EBIT margin35.67%
Net margin-461.48%
ROE-1925.37%
ROA-96.92%
Earnings & Revenue
Revenue (TTM)$885.72M
Revenue growth (1Y)+75.9%
EPS (TTM)-$1.78
Free cash flow$293.05M
Total debt$858.08M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)0.94
Employees435
Next earnings2 Nov '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.